153 related articles for article (PubMed ID: 7778962)
21. Human immunodeficiency virus seroprevalence in an occupational cohort in a South African community.
Kravitz JD; Mandel R; Petersen EA; Nyaphisis M; Human D
Arch Intern Med; 1995 Aug 7-21; 155(15):1601-4. PubMed ID: 7618982
[TBL] [Abstract][Full Text] [Related]
22. [Constant annual incidence of HIV infection among intravenous drug addicts].
Käll K; Olin R
Lakartidningen; 1992 Sep; 89(36):2837-40. PubMed ID: 1405878
[TBL] [Abstract][Full Text] [Related]
23. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A.
Vlahov D; Khabbaz RF; Cohn S; Galai N; Taylor E; Kaplan JE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):89-96. PubMed ID: 7712239
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
Marmor M; Des Jarlais DC; Cohen H; Friedman SR; Beatrice ST; Dubin N; el-Sadr W; Mildvan D; Yancovitz S; Mathur U
AIDS; 1987 May; 1(1):39-44. PubMed ID: 3122788
[TBL] [Abstract][Full Text] [Related]
25. How many people in England and Wales risk infection from injecting drug use?
Durante AJ; Heptonstall J
Commun Dis Rep CDR Rev; 1995 Mar; 5(3):R40-4. PubMed ID: 7536591
[TBL] [Abstract][Full Text] [Related]
26. [Prevalence of HIV-1 infection in intravenous drug dependent patients 1986 to 1989 in Vienna].
Loimer N; Presslich O; Hollerer E; Werner E; Pakesch G; Pfersmann V; Schmid-Siegel B; Aschauer G
Wien Klin Wochenschr; 1990 Feb; 102(4):106-10. PubMed ID: 2316224
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus seropositivity in intravenous drug users in Ohio.
Seligman PJ; Campbell RJ; Keeler GP; Halpin TJ
Ohio Med; 1989 Jan; 85(1):56-9. PubMed ID: 2927870
[TBL] [Abstract][Full Text] [Related]
28. Reducing volunteer bias: using left-over specimens to estimate rates of HIV infection among inmates in Ontario, Canada.
Calzavara LM; Major C; Myers T; Schlossberg J; Millson M; Wallace E; Rankin J; Fearon M
AIDS; 1995 Jun; 9(6):631-7. PubMed ID: 7662204
[TBL] [Abstract][Full Text] [Related]
29. Septic arthritis in patients with acquired immunodeficiency syndrome with human immunodeficiency virus infection.
Rivera J; Monteagudo I; Lopez-Longo J; Sanchez-Atrio A
J Rheumatol; 1992 Dec; 19(12):1960-2. PubMed ID: 1294747
[TBL] [Abstract][Full Text] [Related]
30. Human immunodeficiency virus infection in a Dublin general practice.
Bury G; O'Kelly F
J R Coll Gen Pract; 1989 Mar; 39(320):101-3. PubMed ID: 2555484
[TBL] [Abstract][Full Text] [Related]
31. Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS).
Kingsley LA; Zhou SY; Bacellar H; Rinaldo CR; Chmiel J; Detels R; Saah A; VanRaden M; Ho M; Muñoz A
Am J Epidemiol; 1991 Aug; 134(4):331-9. PubMed ID: 1877593
[TBL] [Abstract][Full Text] [Related]
32. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam.
van Ameijden EJ; van den Hoek JA; van Haastrecht HJ; Coutinho RA
Am J Epidemiol; 1992 Jul; 136(2):236-43. PubMed ID: 1415145
[TBL] [Abstract][Full Text] [Related]
33. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.
Nicolosi A; Leite ML; Musicco M; Molinari S; Lazzarin A
Am J Epidemiol; 1992 Feb; 135(3):225-33. PubMed ID: 1312300
[TBL] [Abstract][Full Text] [Related]
34. Followup study of possible HIV seropositivity among abusers of parenteral drugs in 1971-72.
Lange WR; Ball JC; Adler WH; Brown E; Pyle R; Hoffman W; Dax EM
Public Health Rep; 1991; 106(4):451-5. PubMed ID: 1908596
[TBL] [Abstract][Full Text] [Related]
35. Drug abuse treatment as a strategy to prevent human immunodeficiency virus infection among intravenous drug users. How can we maximize prevention of infection?
West AP
Arch Intern Med; 1991 Aug; 151(8):1493-6. PubMed ID: 1651688
[No Abstract] [Full Text] [Related]
36. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland.
Vlahov D; Muñoz A; Anthony JC; Cohn S; Celentano DD; Nelson KE
Am J Epidemiol; 1990 Nov; 132(5):847-56. PubMed ID: 2239899
[TBL] [Abstract][Full Text] [Related]
37. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.
Vlahov D; Anthony JC; Munoz A; Margolick J; Nelson KE; Celentano DD; Solomon L; Polk BF
NIDA Res Monogr; 1991; 109():75-100. PubMed ID: 1661376
[No Abstract] [Full Text] [Related]
38. [Changes in heroin administration route and frequency of human immunodeficiency virus infection].
Torres-Tortosa M; Ruiz López de Tejada MR; Fernández-Elías M; Pérez-Pérez C; Fernández-Conejero E; Ugarte I; Canueto J
Med Clin (Barc); 1995 Feb; 104(7):249-52. PubMed ID: 7731287
[TBL] [Abstract][Full Text] [Related]
39. Follow up of a cohort of intravenous heroin users in north and south central Dublin and in Dun Laoghaire.
Dean G; Lavelle P; O'Kelly FD; Power B; Hillery I
Ir Med J; 1992 Mar; 85(1):9-10. PubMed ID: 1568857
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.
Metzger DS; Woody GE; McLellan AT; O'Brien CP; Druley P; Navaline H; DePhilippis D; Stolley P; Abrutyn E
J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):1049-56. PubMed ID: 8340896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
